Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TDVAX
- Development stage
- Approved
- Lead developer
- MassBiologics
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
TDVAX is a Tetanus and Diphtheria Toxoids Adsorbed vaccine indicated for active immunization against tetanus and diphtheria in individuals aged 7 years and older. It is manufactured by MassBiologics. The vaccine consists of a combination of detoxified toxins (toxoids) from *Clostridium tetani* and *Corynebacterium diphtheriae*, adsorbed onto aluminum phosphate to enhance the immune response. In the context of Biomat USA, Inc., TDVAX is being evaluated for use in a donor hyper-immunization program, where it is administered at more frequent intervals (every 90 days) than the standard 10-year booster schedule to maintain high levels of anti-tetanus antibodies in plasma donors for the production of Tetanus Immune Globulin (TIG).
- Brand names
- TDVAX
- Other names
- Tetanus and Diphtheria Toxoids AdsorbedTd vaccine
02
Targets
Diphtheria toxin
Beyond the preview
Go deeper on TDVAX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TDVAX.